Select Page

Thursday, 15 Oct, 3:00 PM – 5:00 PM


Research and manufacture of biopharmaceutical products involves the use of genetically engineered (GE) organisms and/or pathogenic organisms. All such organisms are governed under “Rules for the Manufacture, Use/Import/Export and Storage of Hazardous Micro Organisms/ Genetically Engineered Organisms or Cells (Rules,1989)” under the Environment (Protection) Act, 1986. Guidelines have been issued by the Department of Biotechnology (DBT), Government of India for biocontainment requirements for research as well large-scale use.

As per the Indian biosafety regulations, organizations handling genetically modified organisms (GMOs), recombinant DNA materials, and non-GE hazardous microorganisms for research or production purposes are required to constitute an Institutional Biosafety Committee (lBSC). IBSC is the nodal point for implementation of the biosafety guidelines in an institution. The IBSC is one of the key statutory bodies operating directly from the premises of the institution and is responsible for proper implementation of biosafety, rules, regulations, and guidelines. It is mandatory to constitute an IBSC by all institutional handling hazardous microorganisms and/or GE organisms. The IBSCs are set up with approval from the DBT. Compliance and reporting requirement for IBSCs are detailed in Indian Biosafety Knowledge Portal (IBKP), a portal managed by DBT.

The handbook can be accessed here.


  1. Biosafety Regulatory Framework in India: Key Provisions
  2. Key Statutory Bodies and Rules & Regulations in India
  3. Guidelines on Biosafety of Recombinant DNA Research and Biocontainment
  4. Setting up Biocontainment and Biosafety Level Facilities
  5. Implementation Mechanism and Practices in BSL Facilities
  6. Introduction to the Indian Biosafety Knowledge Portal
  7. Roles and Responsibilities of Institutional Bio-Safety Committee (IBSC)
  8. Registration and Approval Process for IBSCs
  9. Sharing of Experience in Working in BSL-3 Facilities by Industry Personnel


1.Dr. Nitin Jain, Scientist F, and Member Secretary, Review Committee on Genetic Manipulation (RCGM), Department of Biotechnology, Govt of India
2.Dr. Vibha Ahuja, Biosafety Expert and Chief General Manager, Biotech Consortium India Limited, New Delhi
3.Dr. Lalitha Gowda, Biosafety Expert, Member, GEAC and Former Chief Scientist, CSIR-CFTRI
4.Dr. Sangeeta Agarwal, Chief Scientific Officer, Biosafety Support Unit, Department of Biotechnology, Govt of India
5.Dr. Pranjal Sharma, Assistant General Manager, Quality Assurance Division, Panacea Biotec Limited, New Delhi

Webinar/Workshop organized by: Birac

iSeekh Disclaimer

We list events as per details provided by the organizer. We are NOT responsible or liable in case of any non-availability or deficiency of the service provided, including any paid event/services.